Inspiritol – A New Investigational Drug Announced for ME/CFS and Long COVID

An “investigational new drug” (IND) application to treat chronic fatigue syndrome (ME/CFS )and long COVID has been filed with the FDA. We don’t see INDs – the documents that begin the drug trial process at the FDA – very often in ME/CFS. They indicate a company is confident enough in … Continue reading Inspiritol – A New Investigational Drug Announced for ME/CFS and Long COVID